Search

everythinglearnresearchcommunity

for

Search:↓

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

PROTO1 and PROTO2 protect against hearing damage.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Progesterone significantly reduces neuroblastoma tumor growth without harming healthy cells.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Combining minoxidil with dutasteride and microneedling is more effective for female pattern hair loss than just dutasteride and microneedling.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Some medications and supplements can affect male fertility, with some improving and others harming sperm quality.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Dihydrotestosterone (DHT) worsens heart enlargement, and blocking it may help prevent heart issues.